Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.
about
Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failureSputum induction as a research tool for sampling the airways of subjects with cystic fibrosisDetermining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.Dyspnea assessment and adverse events during sputum induction in COPD.Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPDSputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.Factors influencing airway inflammation in chronic obstructive pulmonary disease.Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease.Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis.A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.Pulmonary biomarkers in chronic obstructive pulmonary disease.Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis BronchiectasisSputum endothelin-1 level is associated with active pulmonary tuberculosis and effectiveness of anti-tuberculosis chemotherapy.The role of airway secretions in COPD--clinical applications.A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects.The efficiency of sputum cell counts in cystic fibrosis.Airways inflammation and treatment during acute exacerbations of COPD.Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease.Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary diseaseCritical assessment of the value of sputum neutrophils.Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.Long-term effects of budesonide on inflammatory status in COPD.Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.Multicentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstructive pulmonary disease.Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease.Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease.
P2860
Q26749320-28F7B5D2-C4B9-413B-B098-41A8676840B1Q28360550-A4F7F6D8-8E17-428F-87BA-1FAC3C0BF09CQ30882278-C36839C7-5E7E-4ABE-AD4B-6FD8C8E41ACBQ33248387-1EFD9D4D-CD96-4CF4-B3C0-2652AB58ADBCQ33771465-181F0029-2173-468F-8E34-ADDF78027939Q33776839-880017CC-B840-42E0-89BD-B118DFD8305DQ33943545-DD190623-75D2-4612-9648-01BCDC271A71Q34004412-C8E08DDE-2EA2-4FCD-B02F-2B53A370FE6AQ34069584-8141AA46-833F-4C8F-9DB4-D119D1FFC12FQ34184746-30A4B56E-B69E-43BC-B43C-58596485C34EQ34234995-1EF75633-78A4-4B81-BE8D-8162C81E0F4EQ34315062-AB619A43-0DA5-4A12-A63E-D578AD4DF2D3Q34543991-D29AEAB9-E4DE-4C64-96DF-E489DF08C2E4Q34840443-59E29F6A-07C9-42E7-AEF6-8FB898FCA23EQ35533637-04D69352-A526-4734-8D87-FE7EE05F2311Q35535270-42A7BEC0-96F2-4D67-B03D-FCD29A9E058AQ35535368-78BA8855-B771-450E-9411-3DD9B9802D98Q35535433-6723F08E-094A-439F-89DC-1652A43009B0Q35564043-F843D3D5-3518-4467-9785-7120C2EAA2BAQ36225610-7E3272EA-9486-4C6B-943D-1A39C5252696Q36429908-63AE08BB-E04B-4297-9775-DE0CCCE6137DQ36447114-69E27928-64E8-46D0-B62A-E3107D91B905Q36640587-8BBF98BB-91B2-485A-ADC1-AF15018D2D9FQ36674113-517112C8-B344-4CF0-826A-83A719CCCB39Q37063651-C98FDB72-C317-4F7F-8C8D-75044AEB921FQ37177380-36ADF39C-1036-4845-B1CC-20E126D1A1BCQ37237665-C6C7703A-9357-438A-B997-509DA72DE7F9Q37619683-2F026A06-3AAD-43FC-9EFC-7644E85ED5B4Q37875170-4BC6BC0B-F54B-49F2-9EA6-798EA7F31D9FQ38081909-1FB7EBB3-0E72-46D8-81A3-09316823EECCQ40747878-A650BB7D-98E2-4C38-BD39-B6A4CF1F43F7Q42220298-BA160A42-39C4-4FD8-A0FA-F47FF26D24D2Q44398976-D2DB28A8-5ED7-4D5C-A928-1B92607F06CCQ45198841-34403DAC-DB8E-4C70-9505-56FF0E4DAA0FQ45420150-DB2F9C68-351F-4DEA-A763-6AAE18D752BEQ46703864-BD437E54-5D44-492F-905D-5908643DB5D8Q47984688-AAF892F3-6878-4459-8B51-A115110AD41EQ51678656-59395666-7970-4A84-B2BD-074D50AADAD0Q51776344-CF621836-6E92-420A-A68D-7CBA6023A6B7Q53493698-7D59A951-6B29-4CCF-A364-677B2A879056
P2860
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Comparison of spontaneous and ...... obstructive pulmonary disease.
@en
Comparison of spontaneous and ...... obstructive pulmonary disease.
@nl
type
label
Comparison of spontaneous and ...... obstructive pulmonary disease.
@en
Comparison of spontaneous and ...... obstructive pulmonary disease.
@nl
prefLabel
Comparison of spontaneous and ...... obstructive pulmonary disease.
@en
Comparison of spontaneous and ...... obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of spontaneous and ...... obstructive pulmonary disease
@en
P2093
J A Wedzicha
J L Devalia
R J Sapsford
T A Seemungal
P2860
P304
P356
10.1136/THX.53.11.953
P407
P577
1998-11-01T00:00:00Z